The risk and associated factors of methamphetamine psychosis in methamphetamine-dependent patients in Malaysia.
- Authors
- Sulaiman, Ahmad Hatim; Said, Mas Ayu; Habil, Mohd Hussain; Rashid, Rusdi; Siddiq, Amer; Guan, Ng Chong; Midin, Marhani; Nik Jaafar, Nik Ruzyanei; Sidi, Hatta; Das, Srijit
- Year
- 2014
- Journal
- Comprehensive psychiatry
- PMID
- 23433219
- DOI
- 10.1016/j.comppsych.2013.01.003
OBJECTIVE: The objective of this study was to determine the risk of lifetime and current methamphetamine-induced psychosis in patients with methamphetamine dependence. The association between psychiatric co-morbidity and methamphetamine-induced psychosis was also studied. METHODS: This was a cross-sectional study conducted concurrently at a teaching hospital and a drug rehabilitation center in Malaysia. Patients with the diagnosis of methamphetamine based on DSM-IV were interviewed using the Mini International Neuropsychiatric Interview (M.I.N.I.) for methamphetamine-induced psychosis and other Axis I psychiatric disorders. The information on sociodemographic background and drug use history was obtained from interview or medical records. RESULTS: Of 292 subjects, 47.9% of the subjects had a past history of psychotic symptoms and 13.0% of the patients were having current psychotic symptoms. Co-morbid major depressive disorder (OR=7.18, 95 CI=2.612-19.708), bipolar disorder (OR=13.807, 95 CI=5.194-36.706), antisocial personality disorder (OR=12.619, 95 CI=6.702-23.759) and heavy methamphetamine uses were significantly associated with lifetime methamphetamine-induced psychosis after adjusted for other factors. Major depressive disorder (OR=2.870, CI=1.154-7.142) and antisocial personality disorder (OR=3.299, 95 CI=1.375-7.914) were the only factors associated with current psychosis. CONCLUSION: There was a high risk of psychosis in patients with methamphetamine dependence. It was associated with co-morbid affective disorder, antisocial personality, and heavy methamphetamine use. It is recommended that all cases of methamphetamine dependence should be screened for psychotic symptoms.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide association study of stimulant dependence. | 2021 | 34226506 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Factors Associated with Psychosis in 2098 Methamphetamine Users Admitted to 104 Outpatient Counseling Centers in 80 Cities in Turkey. | Guliyev C et al. | — | 2026 | → |
| Stimulant-induced Psychosis: A Comparative Systematic Review and Meta-analysis of Psychotic Outcomes from Therapeutic and Nontherapeutic Use of Stimulants. | Jangra D et al. | — | 2026 | → |
| How does methamphetamine affect the brain? A systematic review of magnetic resonance imaging studies. | Liu GXH et al. | — | 2025 | → |
| Practices and attitudes of adult psychiatrists regarding methamphetamine-associated psychotic disorder: an internet based survey conducted in Turkey. | Örüm MH et al. | — | 2025 | → |
| Factors Associated with Psychotic and Depressive Symptoms in Methamphetamine Users. | Karabulut S | — | 2024 | → |
| Practices and Attitudes of Adult Psychiatrists Regarding Methamphetamine-Associated Psychotic Disorder: An Internet Based Survey Conducted in Turkey | Örüm MH et al. | — | 2024 | — |
| The development and validation of a knowledge, attitude, and practice questionnaire of methamphetamine use. | Azmi AD et al. | — | 2024 | → |
| U.S. trends in methamphetamine-involved psychiatric hospitalizations in the United States, 2015-2019. | Calcaterra SL et al. | — | 2024 | → |
| Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients. | Li Y et al. | — | 2023 | → |
| Single-nucleus transcriptome profiling of prefrontal cortex induced by chronic methamphetamine treatment. | Zeng K et al. | — | 2023 | → |
| Depression in Chinese men with methamphetamine dependence: Prevalence, correlates and relationship with alexithymia. | Li J et al. | — | 2022 | → |
| Leukocyte telomere length is not shortened in methamphetamine dependence or methamphetamine-induced psychosis but is increased following traumatic events. | Rungnirundorn T et al. | — | 2022 | → |
| The Use of Kratom (Mitragyna speciosa Korth.) Among People Who Co-use Heroin and Methamphetamine in Malaysia. | Singh D et al. | — | 2022 | → |
| Direction of the relationship between methamphetamine use and positive psychotic symptoms in regular methamphetamine users: evidence from a prospective cohort study. | Hides L et al. | — | 2021 | → |
| Features of Psychotic Symptoms in Methamphetamine Use Disorder Patients and Ketamine Use Disorder Patients: A Cross-Sectional Study. | Luo T et al. | — | 2021 | → |
| Genome-wide association study of stimulant dependence. | Cox J et al. | — | 2021 | → |
| Anxiety and Depression among Amphetamine-Type Stimulant Users: The Association with Religiosity and Religious Coping. | Tan CH et al. | — | 2020 | → |
| A case of methamphetamine use disorder presenting a condition of ultra-rapid cycler bipolar disorder. | Ikawa H et al. | — | 2019 | → |
| Methamphetamine-associated psychosis: Clinical presentation, biological basis, and treatment options. | Chiang M et al. | — | 2019 | → |
| The role of neurotrophic factors in manic-, anxious- and depressive-like behaviors induced by amphetamine sensitization: Implications to the animal model of bipolar disorder. | Valvassori SS et al. | — | 2019 | → |
| A Research of Methamphetamine Induced Psychosis in 1,430 Individuals With Methamphetamine Use Disorder: Clinical Features and Possible Risk Factors. | Gan H et al. | — | 2018 | → |
| A Review of Risk Factors for Methamphetamine-Related Psychiatric Symptoms. | Chang X et al. | — | 2018 | → |
| A systematic review of risk factors for methamphetamine-associated psychosis. | Arunogiri S et al. | — | 2018 | → |
| Epidemiological Characteristics and Risk Factors of Methamphetamine-Associated Psychotic Symptoms. | Su MF et al. | — | 2018 | → |
| Factors affecting the occurrence of psychotic symptoms in chronic methamphetamine users. | Nie L et al. | — | 2018 | → |
| Profile of psychiatric symptoms in methamphetamine users in China: Greater risk of psychiatric symptoms with a longer duration of use. | Ma J et al. | — | 2018 | → |
| Relationship between the duration of methamphetamine use and psychotic symptoms: A two-year prospective cohort study. | Ma J et al. | — | 2018 | → |
| The management of methamphetamine use in sexual settings among men who have sex with men in Malaysia. | Lim SH et al. | — | 2018 | → |
| The prevalence of substance-induced psychotic disorder in methamphetamine misusers: A meta-analysis. | Lecomte T et al. | — | 2018 | → |
| Gene2DisCo: Gene to disease using disease commonalities. | Frasca M | — | 2017 | → |
| Key differences in treatment-seeking stimulant users attending a specialised treatment service: a means of early intervention? | Arunogiri S et al. | — | 2017 | → |
| Association study of GABA system genes polymorphisms with amphetamine-induced psychotic disorder in a Han Chinese population. | Zhang K et al. | — | 2016 | → |
| Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users. | McKetin R et al. | — | 2016 | → |
| A Study of the Prevalence of Psychiatric Disorders in Patients with Methamphetamine-Induced Psychosis. | Eslami-Shahrbabaki M et al. | — | 2015 | → |
| Adverse childhood experiences and interaction with methamphetamine use frequency in the risk of methamphetamine-associated psychosis. | Ding Y et al. | — | 2014 | → |
| Burden and nutritional deficiencies in opiate addiction- systematic review article. | Nabipour S et al. | — | 2014 | → |
| Methamphetamine psychosis: epidemiology and management. | Glasner-Edwards S et al. | — | 2014 | → |